General MedicationsInjectionGeneric
PROTAMINE SULFATE
PROTAMINE SULFATE
Standard Dose
50MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PROTAMINE SULFATE is listed in Drugs@FDA under application 089307 (ANDA).
Marketing status: Discontinued Active ingredient PROTAMINE SULFATE Form and strength Injectable; Injection - 50MG/VIAL Sponsor QUAD PHARMS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview PROTAMINE SULFATE is listed in Drugs@FDA under application 089307 (ANDA). Marketing status: Discontinued Active ingredient PROTAMINE SULFATE Form and strength Injectable; Injection - 50MG/VIAL Sponsor QUAD PHARMS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.